Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mycobacterioses].

J Grosset, C Sors

    Presse Medicale (Paris, France : 1983)
    |February 4, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Mycobacteriosis, opportunistic infections from atypical mycobacteria, mimic tuberculosis but resist antibiotics. Diagnosis requires repeated isolation, and treatment is often disappointing, with surgery reserved for select cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Expectations in the Development of Computer Technology in Primary Care: A Multidisciplinary Delphi Study Among 23 French Experts.

    Studies in health technology and informatics·2019
    Same author

    Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection.

    Antimicrobial agents and chemotherapy·2010
    Same author

    Bankruptcy of non-surgical treatments for lung abscesses.

    Bulletins et memoires de la Societe medicale des hopitaux de Paris·2010
    Same author

    Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease.

    The European respiratory journal·2005
    Same author

    Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.

    Antimicrobial agents and chemotherapy·2005
    Same author

    Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis.

    Antimicrobial agents and chemotherapy·2005
    Same journal

    Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Ethical, legal, and regulatory challenges in AI-based healthcare tools.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Decision-making for clinicians.

    Presse medicale (Paris, France : 1983)·2026
    See all related articles

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Pathology

    Context:

    • Mycobacteriosis are opportunistic infections caused by atypical mycobacteria.
    • These pathogens present microscopic similarities to Mycobacterium tuberculosis.
    • Clinical manifestations often mimic tuberculosis, affecting lungs, lymph nodes, or skin.

    Purpose:

    • To differentiate mycobacteriosis from tuberculosis based on cultural and biochemical characteristics.
    • To highlight diagnostic criteria for mycobacteriosis.
    • To outline current treatment strategies and their limitations.

    Summary:

    • Atypical mycobacteria cause mycobacteriosis, opportunistic infections with features resembling tuberculosis.
    • Diagnosis relies on repeated isolation of the same atypical mycobacterium from pathological specimens.

    Related Experiment Videos

  • Treatment is challenging due to antibiotic resistance, with limited success except for Mycobacterium kansasii.

    • Impact:

    • Understanding the distinct characteristics of atypical mycobacteria is crucial for accurate diagnosis.
    • Current treatment approaches for mycobacteriosis are often ineffective, necessitating further research.
    • Surgical intervention is a last resort for specific patient profiles with limited disease burden.